405 filings
Page 2 of 21
424B3
7m1ya6
10 May 19
Prospectus supplement
3:26pm
424B3
ftib1bnlqpqqhz sxoid
10 May 19
Prospectus supplement
3:18pm
6-K
hwlqgvlgn34
10 May 19
Primary Document
1:07pm
6-K
3vyjealv1taefk8k7
8 May 19
Intellipharmaceutics Closes US$1.05 Million Convertible Debenture Financing
12:00am
424B3
sp6ueyv2
26 Apr 19
Prospectus supplement
12:13pm
424B3
4jykt53c3kel5ym c6
26 Apr 19
Prospectus supplement
12:10pm
6-K
8rv1ad5 lb
26 Apr 19
Intellipharmaceutics Announces an Update in the Purdue Litigation
12:00am
424B3
bdh7sg7
17 Apr 19
Prospectus supplement
10:49am
424B3
akss6smmas6 jwk48ld
17 Apr 19
Prospectus supplement
10:46am
6-K
1wayy846uc
15 Apr 19
Primary Document
4:25pm
424B3
5pyzb3m h91cf
29 Mar 19
Prospectus supplement
8:57am
424B3
ai6gfha
29 Mar 19
Prospectus supplement
8:55am
6-K
td79z89rovxmgd
29 Mar 19
Primary Document
8:53am
424B3
anjkmrel9
20 Mar 19
Prospectus supplement
7:50am
424B3
dab75prpju
20 Mar 19
Prospectus supplement
7:46am
6-K
gyamth
20 Mar 19
To Begin Trading on the OTC Markets System
12:00am
424B3
an1wlthc3
4 Mar 19
Prospectus supplement
8:34am
424B3
k125v7264psqx pvs
4 Mar 19
Prospectus supplement
8:04am
6-K
mjmkd l5x8mzbiz
4 Mar 19
Intellipharmaceutics Announces Resubmission of New Drug Application to the U.S. FDA for its Oxycodone ER
7:40am
6-K
ewqej 2xjipyk72
4 Mar 19
Primary Document
7:13am